86826-93-9

Basic information

• Product Name: 2-(2-bromo-5-methoxyphenyl)acetic acid
• Synonyms: 2-(2-bromo-5-methoxyphenyl)acetic acid
• CAS NO: 86826-93-9
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.06996
• Mol File: 86826-93-9.mol

Chemical Properties

• Melting Point: 115 °C
• Boiling Point: 362.0±27.0 °C(Predicted)
• Appearance: /
• Density: 1.560±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.94±0.10(Predicted)
• CAS DataBase Reference: 2-(2-bromo-5-methoxyphenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-bromo-5-methoxyphenyl)acetic acid(86826-93-9)
• EPA Substance Registry System: 2-(2-bromo-5-methoxyphenyl)acetic acid(86826-93-9)

Safety Data

• Hazardous Substances Data: 86826-93-9(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-(2-bromo-5-methoxyphenyl)acetic acid is used as a building block for the synthesis of more complex chemical products. Its unique structure, which includes a bromine atom and a methoxy group, allows for a variety of reactions and transformations, making it a valuable component in the creation of new molecules.
Used in Research Investigations:
2-(2-bromo-5-methoxyphenyl)acetic acid is used as a subject of study in various research projects. Its properties, such as the electronegativity of the bromine atom and the potential for hydrophilic interactions due to the methoxy and acetic acid groups, make it an interesting candidate for exploring different chemical reactions and their outcomes.
Used in Pharmaceutical Development:
2-(2-bromo-5-methoxyphenyl)acetic acid is used as a potential starting material in the development of new pharmaceutical compounds. Its unique structure and reactivity may contribute to the creation of novel drugs with specific therapeutic properties, making it a valuable asset in the field of medicinal chemistry.
Used in Material Science:
2-(2-bromo-5-methoxyphenyl)acetic acid is used in the development of new materials with specific properties. Its chemical structure and reactivity may be harnessed to create materials with unique characteristics, such as improved stability, enhanced reactivity, or novel electronic properties, which could be applied in various industries.

Upstream product

• 860758-95-8 (2-bromo-5-methoxy-phenyl)-pyruvic acid 
• 1798-09-0 m-methoxyphenylacetic acid 
• 27387-23-1 5-methoxy-2-bromophenylacetonitrile 
• 19614-12-1 2-bromo-5-methoxybenzyl bromide 
• 27060-75-9 4-bromo-3-methylanisole 
• 7722-84-1 dihydrogen peroxide 

Downstream Products

• 700359-70-2 2-(2-bromo-5-methoxyphenyl)-N-[1-(2-piperidinophenyl)-2-methyl-propyl]acetamide 
• 1350840-07-1 2-(2-bromo-5-methoxyphenyl)-N-methoxyacetamide 
• 1610055-06-5 C₁₆H₁₄Br₂O₃ 
• 1610055-12-3 C₁₂H₁₅BrO₃ 
• 1610055-11-2 C₁₇H₁₇BrO₄ 
• 1610054-74-4 4-methyoxybenzyl 2-(2-bromo-5-methoxyphenyl)-2-diazoacetate 
• 1610055-10-1 C₁₇H₁₇BrO₃ 
• 1610055-09-8 C₁₆H₁₄BrNO₅ 
• 1610055-08-7 C₁₈H₁₇BrO₅ 
• 1610055-07-6 C₁₆H₁₄Br₂O₃ 
• 30414-82-5 ethyl (2-bromo-5-methoxyphenyl)acetate 
• 1610055-02-1 (R)-3-(2-bromo-5-methoxyphenyl)-4,4-dimethyloxetan-2-one 
• 1610054-99-3 (Z)-1-bromo-4-methoxy-2-(4-methylstyryl)benzene 
• 1379477-37-8 2-(2-(4-bromo-2-fluorophenoxy)-5-methoxyphenyl)acetic acid 

Relevant articles and documents

Copper-Catalyzed Lactamization of (E)-2-(2-Bromophenyl)-3-arylacrylamides for the Synthesis of (E)-3-Arylideneindolin-2-ones

A copper-catalyzed, ligand-free intramolecular C-N coupling of (E)-2-(2-bromophenyl)-3-arylacrylamides has been developed. This protocol provides an efficient and practical synthetic route for the biologically important (E)-3-arylideneindolin-2-ones from

INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS

The present invention relates to new inhibitors of Notch signalling pathway and its use in the treatment and/or prevention of cancers.

Simple analogues of natural product chelerythrine: Discovery of a novel anticholinesterase 2-phenylisoquinolin-2-ium scaffold with excellent potency against acetylcholinesterase

As simple analogues of the natural compound chelerythrine, a novel anti-cholinesterase 2-phenylisoquinolin-2-ium scaffold was designed by structure imitation. The activity evaluation led to the discovery of seven compounds with potent anti-acetylcholinesterase activity with IC50 values of ≤0.72 μM, superior to chelerythrine and standard drugs galantamine. Particularly, compound 8y showed the excellent dual acetylcholinesterase-butyrylcholinesterase inhibition activity, superior to rivastigmine, a dual cholinesterase inhibitor drug. Furthermore, the compounds displayed a competitive anti-acetylcholinesterase mechanism with the substrate and low cytotoxicity. Molecular docking showed that the isoquinoline moiety is embedded in a cavity surrounded by four aromatic residues of acetylcholinesterase by the π-π action. Structure-activity relationship showed that the p-substituents on the C-ring can dramatically improve the anti-acetylcholinesterase activity, while 8-OMe can increase the activity against the two cholinesterases simultaneously. Thus, the title compounds emerged as promising lead compounds for the development of novel cholinesterase inhibitor agents.

N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF

A compound of Formula (I) is provided that has been shown to be useful for treating a disease caused by a viral infection: (I) wherein R1, R2, R3, A, L, m, n, p and q are as defined herein.

Chiral Magnesium Bisphosphate-Catalyzed Asymmetric Double C(sp3)-H Bond Functionalization Based on Sequential Hydride Shift/Cyclization Process

Described herein is a chiral magnesium bisphosphate-catalyzed asymmetric double C(sp3)-H bond functionalization triggered by a sequential hydride shift/cyclization process. This reaction consists of stereoselective domino C(sp3)-H bond functionalization: (1) a highly enantio- and diastereoselective C(sp3)-H bond functionalization by chiral magnesium bisphosphate (first [1,5]-hydride shift), and (2) a highly diastereoselective C(sp3)-H bond functionalization by an achiral catalyst (Yb(OTf)3, second [1,5]-hydride shift).

Highly diastereoselective synthesis of tetralin-fused spirooxindoles via lewis acid-catalyzed C(sp3)H bond functionalization

A highly diastereoselective synthesis of tetralin-fused spirooxindole derivatives was described. Treatment of benzylidene oxindoles with a catalytic amount of Sc(OTf)3 in refluxing hexane afforded the target compounds in good chemical yields with excellent diastereoselectivities (up to >20:1). Detailed investigation of the reaction mechanism revealed that both interconversion of the two diastereomers and their solubility difference in reaction medium were the key to achieving excellent diastereoselectivities.

Synthesis, bioactivity and structure-activity relationships of new 2-aryl-8-OR-3,4-dihydroisoquinolin-2-iums salts as potential antifungal agents

As our continuing research on antifungal dihydroisoquinolin-2-ium salts, forty 2-aryl-8-OR-3,4-dihydroisoquinolin-2-ium bromides were synthesized and characterized by spectroscopic analysis. By using the mycelium growth rate method, the compounds were evaluated for antifungal activity against three plant pathogenic fungi and structure-activity relationships (SAR) were derived. The vast majority of the compounds displayed the medium to high activity with inhibition rates of 50-100% at 150 μM. About half of the compounds were more active than their natural model compounds sanguinarine and chelerythrine for all the fungi, and part or most of them were more active than positive drugs thiabendazole and azoxystrobin. SAR analysis showed that both substitution patterns of the C-ring and the type of 8-OR group significantly influenced the activity. Thus, a series of new title compounds with excellent antifungal potency emerged.

Total synthesis of (-)-Haouamine B pentaacetate and structural revision of haouamine B

The enantiocontrolled total synthesis of (-)-haouamine B pentaacetate was accomplished via an optically active indane-fused β-lactam, which was prepared by a newly developed Friedel-Crafts reaction. Subsequent cleavage of the β-lactam and an intramolecular McMurry coupling reaction provided the core indane-fused tetrahydropyridine, which led to the elucidation of the structure, as proposed by Trauner and Zuba.

SPIRO-AMINO-IMIDAZOLONE AND SPIRO-AMINO-DIHYDRO-PYRIMIDINONE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE

The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula (I), wherein variables A1, A3, A4, A5, A6/su

Synthesis of N-alkoxyindol-2-ones by copper-catalyzed intramolecular N-arylation of hydroxamates

The first example of copper-catalyzed intramolecular N-arylation of hydroxamic acid derivatives is presented. Based on this transformation a new method for the synthesis of N-alkoxyindol-2-ones from 2-(2-bromoaryl) acetylhydroxamates has been developed. T